Fritextsökning
Innehållstyper
-
Uppgift: Sanofi planerar avknoppning av sina receptfria läkemedel
Den franska läkemedelsjätten Sanofi uppges ha bett ett antal banker att pitcha för att delta i att hantera företagets planerade avknoppning av sin OTC-verksamhe...
-
IVI’s Director General on establishing in Sweden: Will need up to 40 employees
The International Vaccine Institute, IVI, hopes to have its first staff on-site in Stockholm within a couple of months, says the institute’s Director General Je...
-
Nordic Regulatory experts: Improving biotech chances of Succ
Why is it that so many biotech companies fail? And what are the tools needed to change that fact?
-
Editorial: ”AI that both impresses and frightens”
”In the past, I've rarely been particularly impressed by something that was produced by AI. But this is something completely different”, Samuel Lagercrantz writ...
-
Marie Gårdmark: New incentives for orphan products on its way
"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...
-
Meeting with focus on South Korea and Japan’s life sciences
Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage ...
-
Samuel Lagercrantz: Collaboration and joint efforts are the key to success
Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...
-
Quiet, fast, inexpensive: mass flow controller for life sciences
Whether in portable oxygen system devices or in bioreactors, the new proportional flow control valve VEMD from Festo provides extremely high control dynamics an...
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7 combines high speed digitization and outstanding image quality.
-
Norway finds its path in life science
The life science sector in Norway is on the rise.
-
Column: ”Cheating with pea flowers and does it matter whether you are right?”
Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.
-
Extensive agreements signed at Scilifelab
Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.
-
Meet the governmental life science office
More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...
-
”Bilder är det perfekta målet för AI”
Allt fler lösningar baserade på artificiell intelligens utvecklas och används i vården. Radiologi är ett område som lämpar sig väl för tekniken. Det menar Sophi...
-
The perfect formula for decision-making
No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.
-
Flicka föddes döv – fick hörsel efter genterapi
En ettårig brittisk flicka med medfödd dövhet kan nu höra tack vare genterapi.
-
Camurus flyttar till nytt huvudkontor i Lund
Läkemedelsutvecklaren Camurus har beslutat att flytta sitt huvudkontor till nya lokaler i Science Village i Lund, där man också inrättar ett nytt forskningslabb.
-
FOKUS Patient turns international
FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
Gothenburg-based company acquired by Norwegian diagnostics group
Gentian Diagnostics acquires Gothenburg-based Getica.
-
Extremely high sample throughput rates
Precision and reliability in automated liquid handling
-
Webinar: What is Regulatory Affairs?
This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.
-
Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages
For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...
-
Novo Nordisk invests billions in expanding its production capacity
Danish pharmaceutical company Novo Nordisk is making a major investment to develop and expand its production facility in Hillerød, north of Copenhagen. DKK 15.9...